Drawing for Serial No. 79438465

USPTO serial 79438465

Serial No. 79438465

Reviewed by CopyMark Law Group

Reg. 8387159Status 700Registered
Filing date
Status date
Registration date
Aug 11, 2026
Examiner
WILLIS, ALLYSON B
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79438465?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jordan Arnot Leahey

Jordan Arnot Leahey CM Law LLP13101 Preston Road, Ste. 110-1520Dallas, TX 75240United States

Goods and services

ClassDescriptionStatusFirst use
009Recorded and downloadable artificial intelligence software for healthcare for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; recorded and downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; recorded and downloadable software applications for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; recorded and downloadable application software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; recorded and downloadable computer software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; recorded and downloadable smartphone software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; computer software platforms, recorded or downloadable for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; recorded and downloadable mobile application software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; digital media, namely, downloadable audio and audiovisual recordings featuring information and advice relating to cancer risk, cancer diagnosis, cancer treatment and the clinical needs of patients; multi-platform digital tools, namely, recorded and downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; all of the aforesaid goods for use in relation to and relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients and none of the aforesaid relating to the testing and screening of neurological conditionsACTIVE—
035Data processing services in the field of healthcare; data management, namely, database management, computer data entry services; data processing services; database management; computer data entry services and data processing services; compilation of data for business purposes; automated data processing services; electronic data collection services for business purposes in the fields of medicine and healthcare; systematization of data in computer databases; collating of data in computer databases, namely, compilation and systemization of information into computer databases; market research data analysis; online data processing services; preparation of healthcare statistical data, namely, providing statistical healthcare information for business or commercial purposes; dissemination of data relating to healthcare, namely, providing business information in the field of healthcare, database processing services; data and database improvement, namely, updating and maintenance of data in computer databases; data and database enhancement, namely, updating and maintenance of data in computer databases; combining data from multiple sources into databases, namely, systemization of data in computer databases; information, advisory and consultancy services relating to all of the aforesaid; all of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients and none of the aforesaid relating to the testing and screening of neurological conditionsACTIVE—
041Educational and training services relating to healthcare, namely, conducting training, workshops, classes in the field of healthcare; education services, namely, conducting training, workshops, classes in the field of healthcare; providing of training in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients, rendered through correspondence courses; teaching in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; arranging and conducting of conferences, seminars and training workshops in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; providing education in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients rendered through correspondence courses; educational services, namely, conducting classes, workshops, seminars in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; vocational guidance; organisation of exhibitions for educational purposes; providing on-line non-downloadable electronic publications in the nature of books, magazines, brochures, leaflets in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; information, advisory and consultancy services relating to all of the aforesaid; all of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients and none of the aforesaid relating to the testing and screening of neurological conditionsACTIVE—
042Information technology services for the pharmaceutical and healthcare industries, namely, providing information technology consulting services relating to computer network design, computer software design, and relating to installation, maintenance and repair of computer software, and providing temporary use of online non- downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing online, non-downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable artificial intelligence software for healthcare for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non- downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non- downloadable software applications for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable application software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable computer software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable smartphone software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable mobile application software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; software as a service (SaaS) services featuring software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; platform as a service (PaaS) services featuring computer software platforms for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing online, non-downloadable software platforms for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing online, non-downloadable software, software as a service (SaaS) services featuring software, platform as a service (PaaS) services featuring computer software platforms and online, non-downloadable software platforms all for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; information, advisory and consultancy services relating to all of the aforesaid; all of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients and none of the aforesaid relating to the testing and screening of neurological conditionsACTIVE—
044Healthcare; medical services; hospital services and medical clinics; medical assistance; nursing services; health screening services in the field of cancer; medical information; all of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; advisory and consultancy services relating to all of the aforesaid and none of the aforesaid relating to the testing and screening of neurological conditionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 11, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 11, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 23, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 23, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 18, 2026GPNXNOTIFICATION PROCESSED BY IB—
Jun 17, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 3, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 3, 2026OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 22, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 19, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 19, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 19, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 5, 2026RFNTREFUSAL PROCESSED BY IB—
Feb 19, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 19, 2026RFRRREFUSAL PROCESSED BY MPU—
Jan 24, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 23, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2026DOCKASSIGNED TO EXAMINER—
Dec 15, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 15, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 15, 2025LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Dec 4, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance